Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

News Conference News TCT 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

Todd Neale

September 22, 2018

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

Presentation TCT 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Eric J. Dippel

September 16, 2014

Presentation TCT 2014

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Presenter: Lawrence A. Garcia, Richard M. Green, Douglas E. Drachman, Takao Ohki, MD

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

Presentation TCT 2013

The Multilayer Flow Modulator Stent For The Treatment Of Popliteal Aneurysm.

Presenter: Michel Henry, Amira BENJELLOUN, Isabelle Henry, Antonios Polydorou

January 31, 2013

Presentation TCT 2013

Evaluation of Long-term Vascular Responses to Fluorocopolymer coated Self-Expanding low-dose Paclitaxel-eluting Stent in Porcine Ilio-femoral Model

Presenter: Dongming Hou, Barbara Huibregtse, William Stoffregen, Gordon Kocur, Cory Hitzman, Elizabeth Stejskal, John Heil, Keith Dawkins

January 31, 2013

Presentation TCT 2013

A New Concept Of Stent: The Multilayer Flow Modulator. First Human Study In Peripheral And Visceral Aneurysms

Presenter: Michel Henry, Amira BENJELLOUN, Isabelle Henry, Antonios Polydorou

January 31, 2013

Presentation TCT 2013

Below-Knee Drug Eluting Stents Have Improved Patency, and Symptoms Compared to Bare Metal Stents: a meta-analysis

Presenter: Alexandre Benjo, Francisco Macedo, Emad Aziz, Francisco Nascimento, Fahad Javed, Eyal Herzog, Tyrone Collins, Christopher White

January 31, 2013

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

Presentation TCT 2012

A Prospective, Randomized Trial of Nitinol Stents vs. Balloon Angioplasty in Obstructive Popliteal Lesions

Presenter: Thomas Zeller

October 24, 2012

Presentation TCT 2012

The Multilayer Stent for the Treatment of Popliteal Aneurysm

Presenter: Michel Henry, Amira Benjelloun, Antonios Polydorou, Isabelle Henry

January 03, 2012

Advertisement

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

The Multilayer Flow Modulator Stent For The Treatment Of Popliteal Aneurysm.

Evaluation of Long-term Vascular Responses to Fluorocopolymer coated Self-Expanding low-dose Paclitaxel-eluting Stent in Porcine Ilio-femoral Model

A New Concept Of Stent: The Multilayer Flow Modulator. First Human Study In Peripheral And Visceral Aneurysms

Below-Knee Drug Eluting Stents Have Improved Patency, and Symptoms Compared to Bare Metal Stents: a meta-analysis

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

A Prospective, Randomized Trial of Nitinol Stents vs. Balloon Angioplasty in Obstructive Popliteal Lesions

The Multilayer Stent for the Treatment of Popliteal Aneurysm

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content